Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

PDL BioPharma Inc. (PDLI)

3.08   0.07 (2.33%) 11-19 16:00
Open: 3.01 Pre. Close: 3.01
High: 3.14 Low: 3
Volume: 740,970 Market Cap: 352M
PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing value of its patent.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.14 - 3.151 3.151 - 3.161
Low: 2.969 - 2.983 2.983 - 2.996
Close: 3.058 - 3.077 3.077 - 3.095

Technical analysis

as of: 2019-11-19 4:28:57 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.67     One year: 4.28
Support: Support1: 2.63    Support2: 2.32
Resistance: Resistance1: 3.14    Resistance2: 3.67
Pivot: 2.90
Moving Average: MA(5): 2.99     MA(20): 2.88
MA(100): 2.66     MA(250): 3.01
MACD: MACD(12,26): 0.13     Signal(9): 0.13
Stochastic oscillator: %K(14,3): 90.63     %D(3): 86.73
RSI: RSI(14): 72.03
52-week: High: 3.89  Low: 2.06  Change(%): 6.2
Average Vol(K): 3-Month: 144038  10-Days: 86942

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PDLI has closed above the upper band by 6.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 23.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

PDL BioPharma (PDLI) Q3 Earnings Beat, LENSAR Drives Sales
PDL BioPharma (PDLI) impresses investors with third-quarter earnings beat. LENSAR laser system bumps up sales as well. However, revenues fall year over year.

PDL BioPharma Reports 2019 Third Quarter Financial Results
INCLINE VILLAGE, Nev., Nov. 6, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three and nine months ended September 30, 2019: Third Quarter Financial Highlights Total revenues were $44.2 million, including $20.3 million…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 114.19
Shares Float (M) 96.49
% Held by Insiders 2.47
% Held by Institutions 95.24
Shares Short (K) 11680
Shares Short P. Month (K)

Stock Financials

EPS 0.006
Book Value (p.s.) 5.580
PEG Ratio 1.92
Profit Margin 0.83
Operating Margin -24.74
Return on Assets (ttm) -1.5
Return on Equity (ttm) 0.1
Qtrly Rev. Growth -18.7
Gross Profit (p.s.) 0.543
Sales Per Share
EBITDA (p.s.) -0.116
Qtrly Earnings Growth
Operating Cash Flow (M) -15.37
Levered Free Cash Flow (M) 71.63

Stock Valuations

P/E 513.33
P/E Growth Ratio 0.02
P/BV 0.55
P/S 4.27
P/CF -22.88

Dividends & Splits

Dividend Yield
Dividend Pay Date 2016-06-13
Ex-Dividend Date 2016-06-02
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.